BioWorld

Oct. 20, 2005

'Act Locally' Easier Said Than Done In Chronic Pain Treatment

With Neurodex Filed With FDA, Avanir Raises $16M

Other News To Note

U.S. Patent Disclosures

Gilead Beats Consensus; HIV Drugs Driving Growth

Riding the growth of its HIV franchise, Gilead Sciences Inc. reported solid earnings for the third quarter, beating consensus estimates by a penny. (Bioworld Today) Read More

Fc Regions: Next Advance In Antibody Drug Research

Today's news in brief

BioWorld

BioWorld briefs for Dec. 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 11, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

US lawmakers demand that Kennedy be held accountable

BioWorld

As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...

Medline plans record-setting $5.37B IPO

BioWorld MedTech

Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...